Cynomolgus NKG2A&KLRD1/CD159a&CD94 protein (Recombinant) (C-His&Flag) (STJP020315)
SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant Cynomolgus NKG2A&KLRD1/CD159a&CD94 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Pro94-Leu233) & (Lys32-Ile179) of Cynomolgus NKG2A&KLRD1/CD159a&CD94 (Accession #) fused with His tag
General Information
| Short Description | Recombinant-Cynomolgus NKG2A&KLRD1/CD159a&CD94-C-His&Flag protein was developed in hek293 cells using the region Pro94-Leu233. For use in research applications. |
| Host | HEK293 cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Storage Instruction | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant Cynomolgus NKG2A&KLRD1/CD159a&CD94 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Pro94-Leu233) & (Lys32-Ile179) of Cynomolgus NKG2A&KLRD1/CD159a&CD94 (Accession #) fused with His tag |
| Immunogen Region | Pro94-Leu233 |
Additional Info
| Background | The ligand-receptor assignment between HLA-G and NKG2A/CD94 is dependent of the amino acid composition in the HLA-G heavy chain. Understanding the biophysical basis of receptor-mediated events that lead to NK cell inhibition would help to remove non-tumor reactive cells and support personalized mild autologous NK cell therapies. |
Information sourced from Uniprot.org